10 March, 2017
The compulsory licensing provision is one of the most widely debated provisions of the Patents Act 1970 – both domestically and internationally – as it concerns the grant of a compulsory (manufacturing) licence for a patented drug based on its lack of availability or affordability to the general public.
Please click here for the full article.
For further information, please contact:
Pankaj Musyuni, LexOrbis
mail@lexorbis.com
